Acetyl-d-carnitine

Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2875 references associated with Acetyl-d-carnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Acetyl-d-carnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Alzheimer Disease D000544 76 associated lipids
Parkinson Disease D010300 53 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Cleft Lip D002971 8 associated lipids
Proteostasis Deficiencies D057165 5 associated lipids
Total 7

All references with Acetyl-d-carnitine

Download all related citations
Per page 10 20 50 100 | Total 877
Authors Title Published Journal PubMed Link
Feher J et al. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. 2005 May-Jun Ophthalmologica pmid:15947501
pmid:15966690
pmid:16024206
Bianchi G et al. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. 2005 Eur. J. Cancer pmid:16039110
Ghirardi O et al. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. 2005 Jul-Aug Anticancer Res. pmid:16080512
pmid:1616022
pmid:16169400
Zanelli SA et al. Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. 2005 Ann. N. Y. Acad. Sci. pmid:16179519
pmid:16235010
pmid:16256963
Cavallini G et al. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. 2005 Urology pmid:16286128
pmid:16316746
Kobayashi D et al. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells. 2005 Reproduction pmid:16322553
Schreiber BD Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients. 2006 Blood Purif. pmid:16361853
Flatters SJ et al. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. 2006 Neurosci. Lett. pmid:16406309
pmid:16413418
pmid:16425616
pmid:16433667
pmid:16445703
pmid:16472869

Table of Content